StockData
Skye Bioscience, Inc. logo

Skye Bioscience, Inc. (SKYE) income statement

SKYENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 3/30
$0.79−0.24 (-23.61%)

Close on Nov 19, 2026Market cap $27.87MP/E –Yield –

See a number that looks wrong?